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ABSTRACT 
 
OBJECTIVE:  
The objective of this selective EBM review is to determine whether or not music therapy is 
effective in improving the quality of life in dementia patients.  
 
STUDY DESIGN: 
Review of three English language primary studies published between 1996 and present. 
 
DATA SOURCES:  
Randomized, controlled clinical trials (RCTs) analyzing music therapy and dementia were found 
using PubMed and OVID.  
 
OUTCOMES MEASURED:  
The main outcome measured was quality of life, which included depression, anxiety and 
cognitive change.  
 
RESULTS:  
Music therapy resulted in several beneficial effects for dementia patients including 
improvements in self-esteem, depressive symptoms, anxiety, depression, and cognitive change. 
Participants who attended ≥50% of live music therapy sessions in the Cooke et al study 
experienced improvement in self-esteem over time. Fewer depressive symptoms were reported in 
dementia patients, especially if they had attended music sessions. In the Guétin et al study, both 
anxiety and depression were significantly reduced in participants completing between four and 
sixteen weeks of receptive music therapy (p<0.01). These effects persisted for 8 weeks after 
cessation of intervention. When group music therapy was employed in the Bruer et al study, 
cognitive improvements were found in dementia-diagnosed subjects immediately following 
therapy (+2.00 points) and one day post intervention (+3.69 points) as evident by increased 
scores on the Mini Mental State Exam. One week post-intervention, no significant cognitive 
improvements remained.  
 
CONCLUSIONS:  
The results of these three clinical trials show that the use of music therapy can be effective in 
improving quality of life in some dementia patients. The implementation of music therapy into 
the lives of dementia patients may result in decreased levels of anxiety and depression, higher 
self-esteem, and increased levels of cognition up to one day after therapy. Although the data on 
the persisting effects of music therapy is variable, there is potential for music therapy to have 
effects on anxiety and depression for up to eight weeks following intervention.  
 
 
KEY WORDS: 
Music therapy, depression 
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INTRODUCTION 
 
Dementia is a broad term encompassing several degenerative conditions that are defined 
by significant impairment of mental functioning.  Loss of memory, changes in language, 
behavior and judgment typically lead to substantial impairment of daily functioning. While 
advancements in public health have been successful in lengthening our lifespan, this in turn has 
led to a marked increase in the population of people most susceptible to the disease, the elderly. 
Pharmacological therapy has been effective in controlling symptoms of dementia, but the 
associated side effects have lead patients and providers to desire alternative methods of 
treatment. This paper evaluated two RCTs with blinding of data collectors and one single-center, 
comparative, RCT with blinded assessment of results. Each study evaluated the effectiveness of 
music therapy in improving quality of life in dementia patients. 
Each year, 4.6 million new cases of dementia are diagnosed1. Worldwide, 24.3 million 
people are affected by the disease, and that number is only expected to double by the year 20202. 
These figures are especially staggering for Americans in Assisted Living, where half of residents 
suffer from dementia or some degree of cognitive impairment3. The cost stretches far beyond 
Assisted Living in the United States, amounting to $604 billion worldwide in the year 20104. 
Average individual healthcare costs for people with dementia surpassed $33,000 in 2004, over 
three times the amount paid by people over 65yo without dementia5. This cost discrepancy is no 
surprise considering dementia patients have triple the amount of hospital stays as their non-
affected counterparts and eight times more admissions to skilled nursing facilities than other 
Medicare holders6. Furthermore, for every 1,000 Medicare beneficiaries affected by dementia 
there are 828 hospital stays. Since this population is such high consumers of government-funded 
Medicare and Medicaid services, these programs take the brunt of the financial burden 5.  
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Much of the cost associated with having dementia is due to the overarching effects it has 
on mentation. Alzheimer’s disease, the most common form of dementia, begins with damage to 
brain cells in the segment of the brain where new memories are formed6. With progression, 
symptoms of agitation, aggression, wandering, confusion and apathy result1. Later stages of the 
disease frequently require 24/7 care, as those affected become unable to perform daily activities 
such as bathing, eating and dressing. A diagnosis of dementia is given when a decline in memory 
and one of the following four disabilities is present: a) Failure to speak coherently or understand 
speech or written language b) Inability to recognize or identify objects despite intact sensation c) 
Inability to perform motor tasks, sensory function, or comprehension of the activity d) Lack of 
abstract thought, judgment, and ability to plan and complete complex tasks6. 
Currently, no cure exists for dementia; therefore treatment focuses on controlling the 
symptoms. Five U.S Food and Drug Administration-approved drugs have been found to halt the 
progression of symptoms in dementia patients for up to one year. However, these drugs are 
effective in only 50% of those who take them6. Often, memory loss, behavioral changes and 
sleep disturbances must be managed by separate treatments. Cholinesterase inhibitors and 
memantine are the only two drugs approved for the treatment of cognitive symptoms7. 
Cholinesterase inhibitors work by inhibiting the breakdown of acetylcholine, a chemical vital to 
learning and memory. Memantine, used in more severe forms of Alzheimer’s disease, regulates 
the chemical messenger glutamate and delays declines in learning and memory. Potential side 
effects of these medications include nausea, vomiting, loss of appetite, altered bowel movements, 
headaches and dizziness.  
Antidepressants, anxiolytics, and atypical antipsychotics are commonly used to treat the 
behavioral and psychiatric symptoms of dementia; however, none are specifically approved by 
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the FDA. An increased risk of stroke and death are associated with these medications, therefore 
their use is limited. Alternative treatments have been used to treat the side effects of dementia, 
however a lack of scientific research, uncertainty surrounding their purity, and adverse reactions 
have restricted the extent of their use7.  
Music therapy for the treatment of dementia is being proposed due to the side effects of 
pharmacological therapy and the weak evidence supporting alternative treatments. Specifically, it 
has been explored as a way to communicate to those with dementia who often lose the ability to 
understand and express language in other ways1. Research suggests that the specific area of the 
brain that is responsible for music comprehension persists even after all other functions, 
including verbal language, deteriorate1. Studies evaluating music therapy as an approach for 
improving cognition and behavior in dementia support the safety and efficacy of its use.   
OBJECTIVE 
The objective of this selective EBM review is to determine whether or not music therapy 
is effective in improving quality of life (QOL) in patients with dementia.  To date, recent RCTs 
have identified several positive effects of music therapy that have limited lasting effects1. Music 
therapy may be a safe therapeutic approach for demented patients experiencing behavioral 
disturbances and language deficits that interfere with their everyday life. 
METHODS 
 The three studies analyzed in this review all met the following criteria. The population 
analyzed must consist of older males and females >60yo with a diagnosis of dementia. The 
intervention used in the study must consist of some form of music therapy. Comparison groups 
must include similar participants receiving either reading sessions or age-appropriate movies for 
the same length of time as the music therapy group. The outcomes measured include: QOL and 
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depression, anxiety and depression, and temporal limits of cognitive change. All of these have 
been assessed under one encompassing outcome: quality of life. The types of studies selected are 
all RCTs with blinding of data assessment or data collectors and “intention to treat” analyses. 
Two studies used a cross-overdesign and one study used a single-center, comparative design.  
 A detailed search of the PubMed, OVID and COCHRANE databases was completed by 
the author using the key words “dementia” and “music”. Articles were selected based on their 
relevance to practice and importance to patient-desired outcomes (POEMs: Patient Oriented 
Evidence that Matters). All articles were published in peer-reviewed journals in English 
language. Inclusion criteria for article selection were as follows: RCTs published during or after 
1996 with blinding of results and patient-oriented outcomes. Review articles, meta-analyses and 
systemic reviews posted on the COCHRANE database that answered the same question were 
excluded. Three RCTs were selected and included in this review based on these criteria. Table 1 
displays the demographics and characteristics of these three articles. A summary of statistics 
reported or used include means, p-values, confidence intervals (CIs) and F-scores.  
Table 1- Demographics & Characteristics of included studies 
Study Type # 
pts 
Age Inclusion 
Criteria 
Exclusion 
Criteria 
W/D Interventions 
Bruer3  
2007 
RCT, cross-
over design, 
blinded 
assessors; 
“intent to 
treat” 
17 60+ ; 
mean 
74.1 
Dementia-
diagnosed 
elderly pts on a 
geriatric ward in 
a psych hospital;  
Non-elderly 
status 
(<60yo); 
severe hearing 
loss  
0 8wk-45min 
group music 
therapy session 
using songs 
made popular 
when pts were 
25yo 
Guétin2 
2009 
Single-center, 
comparative 
RCT with 
blinded 
assessment of 
results and 
30 70-95 M/F nursing 
home pts with 
mild-mod 
Alzheimer-type 
dementia; 
Baseline MMSE 
Non-
compliant; 
life-
threatening 
illness; neuro 
d/o, stroke, 
6 Weekly 
receptive music 
therapy 
streamlined 
through 
headphones:  
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“intention-to-
treat” 
analysis 
score 12-25; 
Baseline HAS 
≥12; Adequate 
verbal/written 
expression, 
visual/hearing 
abilities; Prior 
stable ACh tx 
for 6mo 
Parkinson’s 
dz, epilepsy, 
Lewy body 
dementia, 
hallucinations, 
unexplained 
confusion, 
vascular 
dementia, 
frontal 
dementia & 
psych d/o 
1. 20-min 
musical 
sequence 
2. relaxation 
stage 
3. re-enlivening 
phase 
Cooke1 
2010 
RCT cross-
over trial 
with blinding 
of data 
collectors; 
“intention to 
treat” 
47 65-95 M/F with early 
to mid-stage 
dementia; 
MMSE 12-24; 
features 
consistent with 
Alzheimer’s-
type dementia; 
Behavioral hx of 
agitation or 
aggression in 
last 6mo 
None listed by 
author 
0 A live group 
music program 
3 mornings/wk 
for 8wks:   
1. 30min of 
musician-led 
familiar song 
singing  
2. 10min of 
pre-recorded 
instrumental 
music 
 
OUTCOMES MEASURED 
 Outcomes used for analysis include temporal limits of cognitive change, quality of life, 
anxiety and depression. Cooke et al used the Dementia Quality of Life (DQOL) questionnaire 
and Geriatric Depression Scale (GDS) at baseline, mid-point and post-intervention with live 
music groups to assess QOL and depression. The Mini-Mental State Exam (MMSE) was also 
used to determine severity of depression at baseline and post-intervention. Guétin et al used the 
Hamilton Scale to evaluate anxiety and the GDS to determine depression following individual, 
receptive music therapy at weeks 4, 8, 16 and 24. Bruer et al assessed cognitive change before, 
immediately after and remotely after music therapy using the MMSE.  
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RESULTS 
 Three RCTs: two cross-over designs and one single-center study presented in this review, 
evaluated the efficacy of music therapy at improving QOL in dementia patients selected on the 
inclusion criteria found in Table 1. Similar settings were chosen for each sample of elderly 
patients. Trials were carried out with an intention-to-treat analysis of data and further served to 
determine the duration of the therapeutic effect. The primary outcomes of efficacy and duration 
of effect were reported as results in continuous data, rather than numbers-needed-to-treat, in all 
three studies.  
In the Cooke et al randomized, controlled, cross-over study, live group music therapy was 
initiated in order to evaluate its effects on quality of life and depression in dementia patients. 
Forty-seven older males and females diagnosed with mid-stage dementia and a history of 
agitation/aggression were selected between two aged care facilities. Participants were 
randomized to either A) 40 minutes of a live group music program led by 2 musicians, or B) 40 
minutes of an interactive reading session lead by a trained Research Assistant. The music 
program consisted of 30 minutes of music-led familiar song-singing with guitar accompaniment 
and 10 minutes of pre-recorded instrumental music listening. Reading sessions included short-
stories, telling jokes, and reading local news stories. After 8 weeks of intervention, a 5-week 
washout period was implemented, after which participants crossed-over into the opposite arm of 
therapy. Quality of life and depression were evaluated at baseline, midpoint and post-
intervention using the Dementia Quality of Life Scale (DQOL) and Geriatric Depression Scale 
(GDS). Severity of depression was assessed at baseline and post intervention using the Mini-
Mental State Exam (MMSE). Significant findings emerged within two sub-analyses. First, QOL 
self-esteem scores showed a significant improvement in the 24 patients that attended ≥50% of 
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music sessions (F (2,46)=4.471, p<.05), especially from mid-point to post-intervention (3.36-
3.75). Second, patients with scores >5 on the GDS were found to have a significant difference in 
depression scores over time (F (2,22)=8.129, p<.01), especially if they had been in the music 
therapy group (Table 2). In total, 8.7% of the data was found to be missing at random. 
Table 2: Music vs. Reading Therapy: Depression Scores in pts with >5 on GDS (Cook et al) 
 
Group # in study Baseline Mid-point Post-
intervention 
Music Group 12 9.00 6.20 4.40 
Reading Group 12 7.71 6.71 4.43 
 
In the Guétin et al single-center, comparative RCT, two main outcomes were assessed: 1) 
the effect of short and medium-term music therapy on anxiety in dementia patients, and 2) the 
lasting effect of music therapy on depression two months following discontinuation of the 
program. Two groups of 15 male and female subjects received either individual, personally-
selected receptive music therapy or a rest and reading session. Music therapy was administered 
as a 20 minute ‘U sequence’ method which progressively led patients into a state of relaxation 
followed by a period of re-enlivening2.The control group received reading and relaxation therapy 
under the same conditions and time intervals. Anxiety and depression were measured as study 
endpoints at weeks 1, 4, 8, 16 and 24 using the Hamilton Scale (ranging of 0-56) and the GDS, 
(max score 20) respectively. Significant findings emerged between the intervention and control 
group regarding depression and anxiety. As seen in Table 3, by the end of the 16-week 
intervention, anxiety scores for individuals in the music therapy group compared to the control 
group had significantly changed (p<0.001). This change correlated to a 60% improvement in 
anxiety symptoms in the music group versus a 4.8% improvement in the control group. 
Significant persisting effects were also noted at week 24 (p<0.002). 
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Table 3: Change in Anxiety Scores from D0-W16 + follow-up: Music Therapy vs. Control 
Group D0 
 
W16 W24 Approximate improvement 
D0-W16(points) 
Music Therapy 22 (±5.3) 8.4 (±3.7) 10.6 (±6.3) 13.2 (±5.2) 
Control (reading/rest) 21.1 (±5.6) 20.8 (±6.2) 20.5 (±5.4) 0.9 (±7.4) 
 
D0= baseline, Day 0; W16= endpoint, week 16; W24= follow-up, week 24 
In the evaluation of the effect of music therapy on depression, significant findings 
between the two groups emerged by week 16 (p=0.002) and persisted through week 24 (p=0.03) 
(Table 4). Results correlated to a 47% improvement in depressive symptoms for the intervention 
group compared to a 1.7% improvement for participants in the control group. Two patients were 
lost from the intervention group and four patients were lost from the control group, however, all 
data was included in the intent-to-treat analysis.  
Table 4: Change in Depression Scores over Time: Music Therapy vs. Control 
 
Group D0 W16 W24 Approximate Improvement D0-
W16 (points) 
Music Therapy 16.7 (±6.2) 8.9 (±3.3) 12.5 (±6.4) 7.7 (±4.6) 
Control (reading/rest) 11.8 (±7.4) 11.2 (±6.1) 12.1 (±7.6) 0.2 (±4.4) 
 
In the Bruer et al RCT with cross-over design and intent-to-treat analysis, the temporal 
limits of cognitive change were assessed in 17 dementia patients from an inpatient population at 
a geriatric service ward of a psychiatric hospital. Patients were randomly split into two groups 
and offered either group music therapy or an age-appropriate movie once a week. Serving as 
their own controls, participants were then offered the alternative therapy the following week.  
Music therapy followed the ‘Reality Orientation Methodology’ and consisted of popular songs 
from when patients were 25yo. Additional components of music therapy included instrument 
playing and a sing-a-long welcome song. Cognitive assessments were completed during the 8-
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week study using the MMSE at baseline (Time 0: 10am Thursday morning), follow-up 1 (Time 
1: 1 hour following therapy), and follow-up 2 (Time 2: 10am Friday the following morning). A 
significant decline in attendance from 79% in the first half of the study to 67% in the second half 
of the study occurred in dementia patients (p=.030). Music therapy resulted in significant 
improvement in cognitive scores for dementia patients vs. control subjects attending the movie 
(Table 5).  
Table 5: Difference in Mean MMSE Scores for Dementia-Dx: Music Therapy vs. Control3  
Time Period Mean MMSE p-value 95% Confidence 
Interval 
Z p>|z| 
Time 1 (same day) 2.0002 .0463 0.0331-3.9673 1.99 .0463 
Time 2 (next day) 3.6928 .0007 1.5524-5.8332 3.38 .0007 
Time 3 (next week) -0.2958 .5500 -1.2657-0.6741 -0.60 .550 
 
DISCUSSION 
 Overall, these studies indicate that music therapy is effective at improving quality of life 
in dementia patients without the associated side effects of commonly-used medications. 
Although the term “quality of life” has been used in this review to represent several symptoms, 
the effect of music therapy may be applied only to those symptoms discussed in the three 
articles: depression, anxiety, and cognitive change.  
 Cognitive change, which is the most commonly reported side effect of dementia, was 
found to improve following music therapy in 1 of the 3 studies reviewed. In the Bruer et al study, 
MMSE scores significantly improved by 2.00 points on the same day following therapy and 3.69 
points the day after therapy. These findings did not persist into the following week and indicate 
that music therapy may be beneficial for only a short period of time. While the remaining studies 
included assessment of MMSE scores from baseline to post-intervention as an additional 
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analysis, neither one found that music therapy had a significant effect on cognition. However, 
enough evidence exists in current literature to believe that potential effects are possible.  
 Depression, another common symptom of dementia, was evaluated in two studies. In the 
Guétin et al study, a significant decrease in depression scores occurred over time (F(2,22)=8.129, 
p<.01), however, this finding was limited to participants with a score >5 on the GDS and was 
also found in the reading therapy group. These findings may suggest that music therapy may 
only be effective in patients with actual depression opposed to depressive symptoms and that 
reading intervention may be just as effective as music therapy for treating depression. In Guétin 
et al, the music therapy group achieved a 47.1% improvement in depressive symptoms while the 
control group experienced only a 1.7% improvement. Because the two groups differed 
significantly in terms of depressive symptoms at the beginning (mean score of 16.7 in music 
therapy, 11.8 in control, p=0.001), music therapy, therefore, could simply be more effective in 
those with greater depressive symptoms.  
 Anxiety, which was also assessed in the Guétin et al study, improved by 60% in the 
music therapy group versus a 4.3% improvement in the reading control group. Significant 
findings were maintained at follow-up 2 months later. This finding differs from the Bruer et al 
study in which the effect of music therapy on cognition diminished after 1 week. Persisting 
effects of music therapy may then be limited to only certain symptoms of dementia.  
 Research into the use of music therapy in dementia patients thus far has encountered 
several issues to which these studies are no exception. Opinions on whether music therapy 
should be active or receptive, personally-selected or standard, and group or individual still vary. 
The types of music therapy employed by the three articles discussed here were not uniform, a 
difference that may account for some of the variation in observed effects. Though no 
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contraindications to music therapy were found, its use may be limited in the United States where 
insurance largely dictates accessibility to services. In these studies, conducted in Canada, France 
and Australia, insurance coverage did not play a significant role. Most studies additionally seem 
to use musicians or trained professionals and may not have the same effect if other individuals, 
such as at-home providers, administered the therapy.   
CONCLUSION 
It is concluded that music therapy is an effective treatment for patients with dementia. The three 
studies reviewed here show that music therapy can have a significant impact on cognition, agitation, 
depression and self-esteem, all vital components of a person’s quality of life. The results obtained from 
these studies are not without limitations however. Although most of the studies evaluated used a 
significant population size, the sample in Bruer et al amounted to just 17 participants when only those 
with a dementia-diagnosis were considered. Exclusion criteria, furthermore, differed widely between 
studies from none being specifically mentioned (Cooke et al) to exclusion of participants with Lewy body 
dementia, vascular dementia, Parkinson’s disease and unexplained confusion (Guétin).  
 Because of the relative lack of side effects and wide range of benefits, the use of music 
therapy for dementia patients remains a worthwhile topic for research. Future studies would 
benefit by exploring its ability to slow the progression of dementia, opposed to simply alleviating 
the symptoms, with the use of equipment such as MRI. Music therapy’s effects on different 
stages and types of dementia, as well as its use outside of aged care facilities and administration 
only by music therapist may help to clarify the extent of its use.  
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